<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Research in Molecular Medicine</title>
<title_fa>Research in Molecular Medicine</title_fa>
<short_title>Res Mol Med (RMM)</short_title>
<subject>Medical Sciences</subject>
<web_url>http://rmm.mazums.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2322-1348</journal_id_issn>
<journal_id_issn_online>2322-133X</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.29252/rmm</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1397</year>
	<month>11</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2019</year>
	<month>2</month>
	<day>1</day>
</pubdate>
<volume>7</volume>
<number>1</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Investigation of the Impact of Foretinib on AURKA and AURKB Expression in T98 Glioblastoma Cell Line</title>
	<subject_fa>ژنتیک</subject_fa>
	<subject>Genetic</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Background: &lt;/strong&gt;Gliomas are a common type of the primary brain tumors and account for more than 40% of all central nervous system (CNS) tumors. Glioblastoma (GBM) remains one of the most fatal human malignancies as it is highly angiogenic. Foretinib is an oral multikinase inhibitor that has been shown to exhibit antitumor activity in previous clinical studies. &lt;em&gt;AURKA&lt;/em&gt; and &lt;em&gt;AURKB&lt;/em&gt; have been shown to be overexpressed in various cancers. The purpose of this study was to investigate the effect of foretinib on the expression of &lt;em&gt;AURKA&lt;/em&gt; and &lt;em&gt;AURKB&lt;/em&gt; in the T98 cell line.&lt;/div&gt;

&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Materials and Methods:&lt;/strong&gt; I&lt;strong&gt;:&lt;/strong&gt; In this study, the T98 cell line was selected as an experimental model of glioblastoma. The cultured cells were exposed to different concentrations of foretinib (5 &amp;micro;M, 10 &amp;micro;M, 20 &amp;micro;M, and 0 &amp;micro;M as control). Following that, we examined the changes in the expression of &lt;em&gt;AURKA&lt;/em&gt; and &lt;em&gt;AURKB &lt;/em&gt;under the influence of foretinib compared to control using quantitative real-time polymerase chain reaction (qRT-PCR).&lt;/div&gt;

&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Results:&lt;/strong&gt; The expression of &lt;em&gt;AURKA&lt;/em&gt; and &lt;em&gt;AURKB&lt;/em&gt; were found to be significantly reduced in the foretinib treated group compared to the control. The results demonstrated that increasing the concentration of foretinib led to reduction in the expression of both the genes.&lt;br&gt;
&lt;strong&gt;Conclusion:&lt;/strong&gt; These findings indicate that the foretinib can decrease the mRNA levels of &lt;em&gt;AURKA&lt;/em&gt; and &lt;em&gt;AURKB&lt;/em&gt;. Thus, we suggest that foretinib may be an effective drug for GBM treatment and can be considered for future studies.&lt;/div&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>AURKA, AURKB, Foretinib, Glioblastoma</keyword>
	<start_page>1</start_page>
	<end_page>7</end_page>
	<web_url>http://rmm.mazums.ac.ir/browse.php?a_code=A-10-1098-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Mansour</first_name>
	<middle_name></middle_name>
	<last_name>Moghimi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>mansour_moghimi@yahoo.com</email>
	<code>10031947532846007671</code>
	<orcid>10031947532846007671</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Pathology, Shahid Sadoughi University of Medical Sciences, Yazd, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Hossein</first_name>
	<middle_name></middle_name>
	<last_name>Sadeghi Tafti</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>faezenamazi@yahoo.com</email>
	<code>10031947532846007672</code>
	<orcid>10031947532846007672</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Medical Laboratory Sciences, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Faezeh</first_name>
	<middle_name></middle_name>
	<last_name>Namazi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>hossein-t@yahoo.com</email>
	<code>10031947532846007673</code>
	<orcid>10031947532846007673</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Medical Biotechnology Research Center, Ashkezar Branch, Islamic Azad University, Ashkezar, Yazd, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mansoor</first_name>
	<middle_name></middle_name>
	<last_name>Salehi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>M_salehi@med.mui.ac.ir</email>
	<code>10031947532846007674</code>
	<orcid>10031947532846007674</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Molecular, Cellular and Genetics Research Center, Medical Genetics Research Center of GENOME, Isfahan, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
